# Pharmacokinetics of Two Formulations of Entecavir

> **NCT02850848** · PHASE4 · COMPLETED · sponsor: **Yung Shin Pharm. Ind. Co., Ltd.** · enrollment: 39 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Entigin Film Coated Tablet 0.5mg
- **DRUG:** (Baraclude 0.5mg Tablets

## Key facts

- **NCT ID:** NCT02850848
- **Lead sponsor:** Yung Shin Pharm. Ind. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2016-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02850848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02850848, "Pharmacokinetics of Two Formulations of Entecavir". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02850848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*